Alternative Frequency Mapping for Cochlear Implant Users
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how different frequency settings in cochlear implants affect individuals with hearing in only one ear. Participants will use four different sound settings in their new implant to determine which provides the best sound quality and speech understanding. The study aims to discover if changing these settings, known as Alternative Frequency Mapping, can improve hearing experiences and increase device usage. It suits those planning to receive a cochlear implant in one ear while maintaining normal hearing in the other. As an unphased trial, this study allows participants to contribute to innovative research that could enhance cochlear implant technology for future users.
Do I have to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this alternative frequency mapping is safe for cochlear implant users?
Studies have shown that people with cochlear implants generally handle the expected risks well. Research indicates that adjusting sound frequencies in cochlear implants can be fine-tuned to better match natural hearing. This process, called frequency mapping, is being studied to improve sound quality and speech understanding.
There is no direct data on the safety of the specific frequency settings tested in this trial. However, cochlear implant technology has been widely used and is FDA-approved for other uses, suggesting it is generally safe. Most recipients do not experience serious side effects, though some may feel mild discomfort as they adjust to the new sound settings.
Overall, the technology and its adjustments are considered well-tolerated. Participants in this study will try different sound settings to find what works best for them, ensuring safety and comfort.12345Why are researchers excited about this trial?
Most treatments for single-sided deafness with cochlear implants use standard frequency mapping, typically covering the range from 188 to 7938 Hz. However, the alternative frequency mapping being studied introduces maps with higher low-frequency edges starting at 313, 438, and 563 Hz. Researchers are excited about this approach because it allows users to alternate between different frequency maps daily, potentially improving sound quality and user satisfaction. This method offers a personalized experience, enabling users to choose the most comfortable map after trialing different options, which could lead to better auditory outcomes compared to the conventional approach.
What evidence suggests that this alternative frequency mapping is effective for cochlear implant users?
This trial will explore the effects of Alternative Frequency Mapping for cochlear implant users. Research suggests that altering how cochlear implants process sound might enhance hearing. Studies have shown that reducing the mismatch between the implant's sound settings and the ear's natural hearing can increase benefits for users. For instance, adjusting the implant to align with the ear's natural hearing areas may improve speech understanding. Many recipients can adapt to new sound settings, even after prolonged periods without hearing. Overall, these changes could lead to better sound quality and speech understanding for cochlear implant users.45678
Who Is on the Research Team?
Mario A. Svirsky, PhD
Principal Investigator
NYU Langone Health
Are You a Good Fit for This Trial?
This trial is for individuals who have recently received a cochlear implant to address single-sided deafness. Participants should be new users of the device, ready to test different frequency mapping strategies over the first month post-activation.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use four frequency maps for the first month after CI activation, alternating daily, to study adaptation in SSD-CI users.
Follow-up
Participants are monitored for speech perception and sound quality using various frequency maps.
What Are the Treatments Tested in This Trial?
Interventions
- Alternative Frequency Mapping
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator